Thomas Eiwegger

Read how they describe their research on their University of Toronto profile.

• Peanut Oral Immunotherapy Using 30 and 300 mg Maintenance Doses.

  The journal of allergy and clinical immunology. In practice · 2026

• Autoclaved Peanuts Exhibit Reduced Immunoglobulin E Binding and Improved Oral Tolerability.

  Allergy · 2026

• Achieving disease modification with food allergy therapies: An international perspective

  Journal of Allergy and Clinical Immunology · 2026

• Causational Roles of the Gut Microbiome in Childhood Asthma: Leveraging the CHILD Cohort Study

  CIHR · 2019 · Co-investigator

  $1,999,401

• A 15 months, double-Blind, randomized controlled trial comparing 18 weeks of two doses of Omalizumab to placebo to accelerate a symptom-driven Oral immunotherapy schedule in subjects aged 6 to 25 years with Multiple food allergies (BOOM).

  CIHR · 2019 · Co-investigator

  $267,750

• Causational Roles of the Microbiome in Childhood Asthma: Leveraging the CHILD Study

  CIHR · 2018 · Co-investigator

  $24,875